We are live on ! Find out more
CA

Calton & Associates Portfolio holdings

AUM $683M
1-Year Est. Return 28.95%
This Fund
S&P 500
This Quarter Est. Return
+8.07%
1 Year Est. Return
+28.95%
3 Year Est. Return
+73.86%
5 Year Est. Return
+79.5%
10 Year Est. Return
AUM
$487M
AUM Growth
+$27.9M
Cap. Flow
-$1.78M
Cap. Flow %
-0.36%
Top 10 Hldgs %
38.41%
Holding
369
New
37
Increased
143
Reduced
151
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 6.98%
2 Healthcare 4.02%
3 Financials 2.55%
4 Consumer Discretionary 2.48%
5 Communication Services 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNP icon
326
DNP Select Income Fund
DNP
$4.1B
$136K 0.03%
+13,532
New +$144K
OMER icon
327
Omeros
OMER
$984M
$134K 0.03%
13,249
-1,309
-9% -$16.9K
GE icon
328
GE Aerospace
GE
$382B
$124K 0.03%
3,997
-3,676
-48% -$119K
FULT icon
329
Fulton Financial
FULT
$4.65B
$122K 0.03%
13,026
+2,850
+28% +$28K
HPE icon
330
Hewlett Packard
HPE
$72B
$116K 0.02%
12,342
-578
-4% -$5.52K
KMDA icon
331
Kamada
KMDA
$409M
$108K 0.02%
12,969
-731
-5% -$6.64K
PMM
332
Franklin Managed Municipal Income Trust
PMM
$273M
$105K 0.02%
13,683
TCPC icon
333
BlackRock TCP Capital
TCPC
$327M
$105K 0.02%
+10,718
New +$104K
NMFC icon
334
New Mountain Finance
NMFC
$730M
$100K 0.02%
+10,452
New +$101K
OCSL icon
335
Oaktree Specialty Lending
OCSL
$1.13B
$86K 0.02%
+5,956
New +$85.1K
MRCC
336
DELISTED
Monroe Capital Corp
MRCC
$73K 0.02%
+10,665
New +$72.9K
ACB
337
Aurora Cannabis
ACB
$216M
$71K 0.01%
+1,519
New +$144K
HIE
338
DELISTED
Miller/Howard High Income Equity Fund
HIE
$65K 0.01%
10,631
-34
-0.3% -$216
SIRI icon
339
SiriusXM
SIRI
$9.61B
$58K 0.01%
1,082
+7
+0.7% +$401
ATRS
340
DELISTED
Antares Pharma, Inc.
ATRS
$55K 0.01%
20,500
MRO
341
DELISTED
Marathon Oil Corporation
MRO
$49K 0.01%
12,000
SRGA
342
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$46K 0.01%
845
-550
-39% -$42.1K
ZAGG
343
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$44K 0.01%
15,835
-361
-2% -$1.13K
ADAM
344
Adamas Trust
ADAM
$919M
$37K 0.01%
3,606
+59
+2% +$615
RKDA icon
345
Arcadia Biosciences
RKDA
$1.46M
$36K 0.01%
325
TXMD icon
346
TherapeuticsMD
TXMD
$24M
$30K 0.01%
380
+40
+12% +$3.19K
BGC icon
347
BGC Group
BGC
$4.83B
$25K 0.01%
10,420
PTN
348
Palatin Technologies
PTN
$13.2M
$16K ﹤0.01%
27
AMAT icon
349
Applied Materials
AMAT
$417B
-4,313
Closed -$261K
BMRN icon
350
BioMarin Pharmaceuticals
BMRN
$13.5B
-1,693
Closed -$209K

Similar funds

Calton & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Calton & Associates held 369 positions worth $487M, up 6.1% from $459M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Calton & Associates's Q3 2020 filing shows 37 new, 143 increased, 151 reduced and 21 closed positions. Its largest new stake was SPDR Gold MiniShares Trust: 25,801 shares worth $970K. The largest sale was iShares Russell 1000 Value ETF, an estimated $4.68M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.

  • Calton & Associates's largest Q3 2020 buy was SPDR Gold MiniShares Trust: 25,801 shares worth $970K.
  • Calton & Associates added most to iShares Core Universal USD Bond ETF in Q3 2020, an estimated $7.73M increase.
  • Calton & Associates's biggest Q3 2020 reduction was iShares Russell 1000 Value ETF, cutting an estimated $4.68M.
  • Calton & Associates fully exited iShares Gold Trust in Q3 2020, selling an estimated $1.03M.
  • Calton & Associates's ten largest holdings make up 38% of its $487M portfolio in Q3 2020.
  • Calton & Associates opened 37 new positions and closed 21 in Q3 2020.
  • Calton & Associates's portfolio value rose 6.1% quarter-over-quarter to $487M.

Based on Calton & Associates's 13F filing for Q3 2020, filed 30 Oct 2020.